HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Development of hepatic angiomyolipoma accompanied with focal nodular hyperplasia long after treatment of pelvic rhabdomyosarcoma.

Abstract
Survivors of childhood cancer have a higher risk of developing a secondary neoplasm in their lifetime. The increased risk of a second malignant neoplasm is related to treatment of the primary tumor and genetic predisposition. We describe a 19-year-old man with 2 hepatic masses, one of which was diagnosed as a hepatic angiomyolipoma and the other as focal nodular hyperplasia 14 years after the treatment of stage IV pelvic rhabdomyosarcoma. The combination of these tumors has not previously been reported in the literature.
AuthorsMasaki Honda, Kwang-jong Lee, Shintaro Hashimoto, Shintaro Hayashida, Hiroko Suda, Yuki Ohya, Hidekazu Yamamoto, Takayuki Takeichi, Katsuhiro Asonuma, Yukihiro Inomata
JournalJournal of pediatric surgery (J Pediatr Surg) Vol. 46 Issue 6 Pg. 1267-70 (Jun 2011) ISSN: 1531-5037 [Electronic] United States
PMID21683235 (Publication Type: Case Reports, Journal Article)
CopyrightCopyright © 2011 Elsevier Inc. All rights reserved.
Topics
  • Angiomyolipoma (pathology, surgery)
  • Biopsy, Needle
  • Focal Nodular Hyperplasia (pathology, surgery)
  • Follow-Up Studies
  • Hepatectomy (methods)
  • Humans
  • Immunohistochemistry
  • Liver Neoplasms (pathology, surgery)
  • Magnetic Resonance Imaging (methods)
  • Male
  • Neoplasm Staging
  • Neoplasms, Second Primary (pathology, surgery)
  • Pelvic Neoplasms (pathology, surgery)
  • Rare Diseases
  • Rhabdomyosarcoma (pathology, surgery)
  • Risk Assessment
  • Time Factors
  • Tomography, X-Ray Computed (methods)
  • Treatment Outcome
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: